Insulin glulisine in the management of diabetes

被引：9

作者：

Yamada, Satoru ^{[1
,2
]}

机构：

[1] Kitasato Inst Hosp, Diabet Ctr, Tokyo, Japan

[2] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan

来源：

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2009年 / 2卷

关键词：

insulin analog; rapid-acting insulin; trometamol; polysorbate; 20;

D O I：

10.2147/DMSO.S3404

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Insulin glulisine is appealing in principle, but the advantages of this drug over the other rapid-acting insulin analogs are still relatively unknown. The frequency of hypoglycemia, convenience in the timing of administration, and improvements in terms of HbA(1c) seem similar among the rapid-acting insulin analogs, including insulin glulisine. Only properly randomized long-term clinical studies with insulin glulisine will reveal the true value of this novel insulin analog.

引用

页码：111 / 115

页数：5

共 34 条

[1]

Annuzzi G, 2001, NUTR METAB CARDIOVAS, V11, P168

[2] Clinical pharmacokinetics and pharmacodynamics of insulin glulisine [J].

Becker, Reinhard H. A. ;

Frick, Annke D. .

CLINICAL PHARMACOKINETICS, 2008, 47 (01) :7-20

[3] Insulin glulisine complementing basal insulins: A review of structure and activity [J].

Becker, Reinhard H. A. .

DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (01) :109-121

[4] Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects [J].

Becker, RHA ;

Frick, AD ;

Burger, F ;

Potgieter, JH ;

Scholtz, H .

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (08) :435-443

[5] Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes [J].

Bott, U ;

Ebrahim, S ;

Hirschberger, S ;

Skovlund, SE .

DIABETIC MEDICINE, 2003, 20 (08) :626-634

[6] MONOMERIC INSULINS AND THEIR EXPERIMENTAL AND CLINICAL IMPLICATIONS [J].

BRANGE, J ;

OWENS, DR ;

KANG, S ;

VOLUND, A .

DIABETES CARE, 1990, 13 (09) :923-954

[7] Insulin glulisine provides improved glycemic control in patients with type 2 diabetes [J].

Dailey, G ;

Rosenstock, J ;

Moses, RG ;

Ways, K .

DIABETES CARE, 2004, 27 (10) :2363-2368

[8] Efficacy and safety of insulin glulisine in patients with type 1 diabetes [J].

Dreyer, M ;

Prager, R ;

Robinson, A ;

Busch, K ;

Ellis, G ;

Souhami, E ;

Van Leendert, R .

HORMONE AND METABOLIC RESEARCH, 2005, 37 (11) :702-707

[9] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].

Duckworth, William ;

Abraira, Carlos ;

Moritz, Thomas ;

Reda, Domenic ;

Emanuele, Nicholas ;

Reaven, Peter D. ;

Zieve, Franklin J. ;

Marks, Jennifer ;

Davis, Stephen N. ;

Hayward, Rodney ;

Warren, Stuart R. ;

Goldman, Steven ;

McCarren, Madeline ;

Vitek, Mary Ellen ;

Henderson, William G. ;

Huang, Grant D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62

[10] Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin [J].

Ferguson, SC ;

Strachan, MWJ ;

Janes, JM ;

Frier, BM .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2001, 17 (04) :285-291

← 1 2 3 4 →